Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Director/PDMR Shareholding

28 Nov 2016 10:00

RNS Number : 3007Q
Adamas Finance Asia Limited
28 November 2016
 

ADAMAS FINANCE ASIA LIMITED

(ADAM or the "Company")

Director/PDMR Shareholding

 

 

The Company was notified on 28 November 2016 that Barry Lau, Managing Partner of the Company's investment manager, Adamas Asset Management (HK) Limited, had acquired 25,000 ordinary shares of no par value each in ADAM on the dates detailed below:

 

Date

Purchase price (US$)

No. of shares acquired

 

 

 

24 November 2016

0.560

10,000

25 November 2016

0.560

15,000

 

Following these transactions, Mr Lau is interested in 420,000 ordinary shares, representing 0.22% of the Company's issued share capital.

 

The attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 Barry Lau

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Partner of the Company's investment manager, Adamas Asset Management (HK) Limited

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Adamas Finance Asia Limited

b)

 

LEI

 

 

-

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of no par value in Adamas Finance Asia Limited

 

VGG008271162

 

 

b)

 

Nature of the transaction

 

 

Acquisition of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

0.560

0.560

10,000

15,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

25,000

 

 

US$14,000

 

e)

 

Date(s) of the transaction

 

 

24 and 25 November 2016

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

Enquiries:

Adamas Finance Asia Limited

 

John Croft, Non-Executive Chairman

+44 (0) 1825 830 587

 

 

Nominated Adviser:

 

WH Ireland Limited

+44 (0) 113 394 6600

Tim Feather

 

Ed Allsopp

 

 

 

Broker:

 

finnCap Limited

+44 (0) 20 7220 0500

William Marle

 

Grant Bergman

 

 

 

 

 

Public Relations Advisers:

 

First City Public Relations (Hong Kong)

+852 2854 2666

Allan Piper

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKVLBLQFFEFBQ
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.